Point prevalence of surgical checklist use in Europe: relationship with hospital mortality by Jammer, I. et al.
Point prevalence of surgical checklist use in Europe:
relationship with hospital mortality
I. Jammer1,2, T. Ahmad3, C. Aldecoa4, D. Koulenti5,6, T. Goranovic´7, I. Grigoras8, B. Mazul-Sunko7,9, R. Matos10,
R. Moreno10, G. H. Sigurdsson11, P. Toft12, B. Walder13, A. Rhodes14 and R. M. Pearse3* for the European Surgical
Outcomes Study (EuSOS) group†
1 Department of Clinical Medicine, University of Bergen, Bergen 5021, Norway
2 Department of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen 5021, Norway
3 Queen Mary University of London, London E1 4NS, UK
4 Department of Anesthesia and Surgical Critical Care, Hospital Universitario Rio Hortega, Valladolid 47012, Spain
5 2nd Critical Care Department, Attikon University Hospital, Athens 12462, Greece
6 Burns, Trauma and Critical Care Research Centre, University of Queensland, Brisbane, QLD 4006, Australia
7 Department of Anaesthesiology and Intensive Care Medicine, University Hospital Sveti Duh, Zagreb 10000, Croatia
8 Anesthesia and Intensive Care Department, Regional Institute of Oncology, University of Medicine and Pharmacy ‘Gr. T. Popa’, Iasi 700483,
Romania
9 Medical School of J.J. Strossmayer University, Osijek 31000, Croatia
10 UCINC, Hospital de Sa˜o Jose´, Centro Hospitalar de Lisboa Central, EPE, Lisboa 1150-199, Portugal
11 Landspitali Unversity Hospital, University of Iceland, 101 Reykjavik, Iceland
12 Anaesthesia and Intensive Care, Odense University Hospital, Odense 5000, Denmark
13 Postanaesthesia and Intermediate Care Unit, University Hospitals of Geneva, Geneva 1211, Switzerland
14 Critical Care, St George’s Healthcare NHS Trust and St George’s University of London, London SW17 0QT, UK
* Corresponding author. Adult Critical Care Unit, Royal London Hospital, London E1 1BB, UK. E-mail: r.pearse@qmul.ac.uk
Editor’s key points
† Checklists promote
recollection of
recommended steps or
actions, overcoming
lapses in memory and
attention.
† Clinical team participation
in a checklist procedure
should enhance
communication.
† Checklists are a tool, not a
replacement for adequate
training and supervision,
vigilance, and teamwork.
† The consistent
relationship between
checklist use and better
outcomes probably
indicates direct (causal)
and indirect beneficial
effects.
Background. The prevalence of use of the World Health Organization surgical checklist is
unknown. The clinical effectiveness of this intervention in improving postoperative outcomes
is debated.
Methods.We undertookaretrospective analysis ofdatadescribingsurgical checklist use froma 7
day cohort study of surgical outcomes in 28 European nations (European Surgical Outcomes
Study, EuSOS). The analysis included hospitals recruiting .10 patients and excluding outlier
hospitals above the 95th centile for mortality. Multivariate logistic regression and three-level
hierarchical generalized mixed models were constructed to explore the relationship between
surgical checklist use and hospital mortality. Findings are presented as crude and adjusted
odds ratios (ORs) with 95% confidence intervals (CIs).
Results. A total of 45 591 patients from 426 hospitals were included in the analysis. A surgical
checklist was used in 67.5% patients, with marked variation across countries (0–99.6% of
patients). Surgical checklist exposure was associated with lower crude hospital mortality (OR
0.84, CI 0.75–0.94; P¼0.002). This effect remained after adjustment for baseline risk factors in
a multivariate model (adjusted OR 0.81, CI 0.70–0.94; P,0.005) and strengthened after
adjusting for variations within countries and hospitals in a three-level generalized mixed
model (adjusted OR 0.71, CI 0.58–0.85; P,0.001).
Conclusions. The use of surgical checklists varies across European nations. Reported use of a
checklist was associated with lower mortality. This observation may represent a protective
effect of the surgical checklist itself, or alternatively, may be an indirect indicator of the quality
of perioperative care.
Clinical trial registration. The European Surgical Outcomes Study is registered with
ClinicalTrials.gov, number NCT01203605.
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It is estimated that more than 230 million patients undergo
surgery worldwide each year, with mortality rates reported to
be between 1 and 4%.1 – 3 Variations in mortality between
hospitals suggest both the potential and the need to improve
outcomes resulting from preventable adverse events.3 – 9 Con-
sequently, there is increasing focus on improving the quality
of perioperative care to minimize adverse events, and hence
postoperative mortality. The World Health Organization (WHO)
surgical checklist is a simple intervention designed to reduce
error rates during surgeryand anaesthesia.10 By improving com-
munication within the surgical team, checklist use may improve
hazard detection, leading to meaningful improvements in
patient safety.11 12
The first report of the use of the WHO surgical checklist was
a cohort study, in which implementation was associated with a
decrease in adverse event rates from 11 to 7% and a reduction
in mortality from 1.5 to 0.8%.10 These preliminary findings
were consistent with subsequent studies, with reports of
reductions in adverse event rates13 14 and mortality.13 – 15
Checklists improve teamwork and communication in the oper-
ating theatre, which may be one explanation for improved
patient outcomes.16 These improvements in outcomes may
also result in economic benefits.17 Despite the strong argu-
ments in support of surgical checklist implementation, there
is anecdotal evidence of wide variation in use between hospi-
tals and nations. However, there have been no international
epidemiological studies of surgical checklist use, or associated
mortality, to confirm or refute this proposition. The aim of our
study was to describe the prevalence of surgical checklist use
in patients recruited to the European Surgical Outcome Study
(EuSOS),3 and to establish whether there is any relationship
between reported use of a surgical checklist and subsequent
hospital mortality.
Methods
Data collection
This was a secondary analysis of the European Surgical
Outcome Study (EuSOS) data set.3 The EuSOS was an observa-
tional study including all patients aged 16 years and over
undergoing non-cardiac surgery in participating hospitals
during the 7 day cohort week between April 4 and April 11,
2011. Patients undergoing planned day-case surgery, cardiac
surgery, neurosurgery, radiological, or obstetric procedures
were excluded. A paper case record form was completed for
consecutive eligible patients. This was then anonymized
before data entry onto a secure Internet-based electronic
case record form. Patients were followed up until hospital
discharge for data describing hospital mortality, censored at
60 days after surgery. We assessed data for completeness
and then checked for plausibility and consistency with pro-
spectively defined ranges. As part of the prospective data set,
investigators were asked to record whether a surgical checklist
was used in the care of each individual patient. No other details
were requested regarding how the checklist was used. Ethical
requirements differed by country. In Denmark, centres were
exempt from ethical approval because the study was deemed
to be a clinical audit. In all other nations, formal ethical approv-
al was obtained. Informed consent was obtained from patients
where required by local research ethics committees. A list
of participating hospitals and full details of the methodology
of the study can be found in the original publication.3 To
improve data quality, the primary analysis was performed on a
data set that excludes sites with ≤10 patients and sites above
the 95th centile for mortality. A sensitivity analysis was con-
ducted on the entire data set.
Statistical analysis
The mortality outcome was defined as death in hospital within
60 days of surgery. Patients were categorized according
to baseline demographics, including age, gender, smoking
status, ASA physical status score, urgency of surgery, grade of
surgery, surgical procedure category, and co-morbid disease.
A single-level binary logistic regression model was used to
conduct univariate analysis of the effect of surgical checklist
use on hospital mortality. We then constructed a multivariate
logistic regression model to compare the use of surgical check-
list across these categories. Factors were entered into the
multivariate logistic regression model according to their asso-
ciation with mortality in the univariate logistic regression
analysis (P,0.05). To adjust for likely variations within coun-
tries and hospitals, a hierarchical three-level generalized
mixed model was developed, with patients as the first level,
hospital as the second level, and countries as the third level.
The model was constructed with and without the surgical
checklist as avariable in order to compare the effect on hospital
mortality. Categorical variables are presented asn (%) and con-
tinuous variables as mean (SD). Findings are presented as odds
ratios (ORs) with 95% confidence intervals (CIs). Adjusted ORs
are presented with crude ORs for comparison. All data analysis
was conducted using SPSS version 21 for Windows (IBM SPSS
Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.).
Statistical significance was set at P,0.05.
Results
The EuSOS database consists of 46 539 patients from 498
hospitals. Of these, 45 591 patients from 426 sites were
included in the primary analysis, with an overall hospital mor-
tality of 3.0%. Baseline data are presented in Table 1 along with
the likelihood of exposure to a surgical checklist according to
these factors. There was wide variation in exposure to a surgi-
cal checklist according to baseline characteristics. The overall
prevalence of surgical checklist use in this population was
67.5%, but there was marked variation between countries
from 0 to 99.6%. There was no clear relationship between pat-
terns of checklist use and mortality rates in individual countries
(Fig. 1 and Supplementary Table 1).
The use of a surgical checklist was associated with a lower
crude hospital mortality (OR 0.84, CI 0.75–0.94; P¼0.002).
This effect was strengthened after adjustment for baseline
risk factors in a multivariate regression model (adjusted
OR 0.81, CI 0.70–0.94; P,0.005). To account for the effect
of variation within countries and hospitals, we then
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constructed a three-level mixed model (Table 2). The find-
ings of this analysis suggest that exposure to a surgical
checklist is associated with lower hospital mortality
(adjusted OR 0.71, CI 0.58–0.85; P,0.001). In a sensitivity
analysis including all patients in the original EuSOS cohort
(i.e. not excluding sites recruiting a small number of patients
or those above the 95th centile for mortality), the equivalent
three-level generalized mixed model was constructed, with
similar findings (Supplementary Table 2). Exposure to a sur-
gical checklist was associated with lower crude hospital
mortality (OR 0.64, CI 0.59–0.71; P,0.001), although this
effect was reduced after adjustment for confounding
factors (adjusted OR 0.88, CI 0.77–1.01; P,0.06). Whilst
mortality after surgery increases with more urgent surgical
procedures, the apparent protective effect of the surgical
checklist remains, regardless of the urgency of surgery (Sup-
plementary Table 3).
Discussion
The principal finding of our study was that there were wide
variations in exposure to surgical checklist use between Euro-
pean nations. Exposure was associated with a lower hospital
mortality after adjustment for risk factors, which may differ
between hospitals and countries. Overall, only two-thirds of
patients who underwent surgery in this study were exposed
to a surgical checklist. The findings of a sensitivity analysis in-
cluding all hospitals were similar, although the observed
effect of the checklist was weaker. It is unclear whether
these observations relate to a protective effect of the surgical
Table 1 Baseline data describing differences in exposure to a surgical checklist. Odds ratios with 95% confidence intervals (CIs) were constructed
for use of surgical checklist using multivariate logistic regression analysis, adjusting forage, ASA class, urgencyof surgery, grade of surgery, surgical
speciality, and the presence or absence of co-morbid disease. COPD, chronic obstructive pulmonary disease
Baseline data Number of patients (%) Checklist use (%) Odds ratios (95% CI) for checklist exposure P-value
Men 22 126 (48.5%) 67.3 0.96 (0.92–1.00) 0.06
Current smoker 9669 (21.2) 65.6 0.93 (0.88–0.97) ,0.001
ASA class
I 11 400 (25.0) 68.2 Reference –
II 21 122 (46.3) 67.5 0.85 (0.81–0.90) ,0.001
III 11 362 (24.9) 66.8 0.80 (0.74–0.86) ,0.001
IV 1527 (3.3) 65.0 0.67 (0.59–0.76) ,0.001
V 88 (0.2) 59.1 0.46 (0.30–0.76) ,0.001
Grade of surgery
Minor 11 838 (26.0) 64.0 Reference –
Intermediate 21 793 (47.8) 65.9 1.08 (1.03–1.13) ,0.001
Major 11 863 (26.0) 73.5 1.50 (1.41–1.59) ,0.001
Urgency of care
Elective 34 284 (75.2) 66.6 Reference –
Urgent 8778 (19.3) 70.2 1.16 (1.10–1.23) ,0.001
Emergency 2519 (5.5) 70.2 1.16 (1.05–1.27) ,0.001
Surgical procedure category
Orthopaedics 11 877 (26.1) 71.6 1.42 (1.31–1.55) ,0.001
Breast 1482 (3.3) 74.1 1.72 (1.50–1.98) ,0.001
Gynaecology 3900 (8.6) 67.8 1.26 (1.14–1.40) ,0.001
Vascular 2334 (5.1) 63.9 1.09 (0.98–1.22) 0.13
Upper gastrointestinal 2183 (4.8) 71.4 1.42 (1.26–1.60) ,0.001
Lower gastrointestinal 4871 (10.7) 70.5 1.32 (1.20–1.45) ,0.001
Hepatobiliary 2177 (4.8) 58.8 0.86 (0.77–0.97) 0.01
Plastic or cutaneous 2391 (5.2) 64.8 1.17 (1.05–1.30) 0.01
Urology 4824 (10.6) 67.7 1.28 (1.17–1.41) ,0.001
Kidney 457 (1.0) 73.1 1.46 (1.17–1.82) ,0.001
Head and neck 5565 (12.2) 61.4 1.01 (0.93–1.11) 0.80
Other 3387 (7.4) 61.8 Reference –
Co-morbid disease
COPD 5075 (11.1) 72.3 1.37 (1.28–1.47) ,0.001
Coronary artery disease 6121 (13.4) 61.1 0.68 (0.64–0.73) ,0.001
Diabetes (not taking insulin) 3417 (7.5) 64.9 0.90 (0.83–0.97) 0.01
Hospital mortality (%) 1362 (3.0) 57.4 0.65 (0.59–0.71) ,0.001
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checklist itself or whether this is merely a process measure
reflecting higher quality of perioperative care.
The surgical checklist has been widely adopted in nations of
differing economic status.12 This hospital-level intervention
cannot be studied in a simple randomized trial, and we must
therefore depend on alternative methods of health services re-
search to test the effects of exposure to a checklist, in particu-
lar, associations with mortality. The original report by Haynes
and colleagues11 described a simple cohort study of cluster
trial design, suggesting that the checklist was associated
with a reduction in postoperative mortality. Whilst these
findings were the subject of debate, the outcome of two subse-
quent studies, a cluster trial and a retrospective epidemiologic-
al study, both from The Netherlands, also indicated an
association with improved mortality.14 15 A prospective study
in orthopaedic patients did not show any association with
reduced mortality, but suggested that early education and
system change can increase accurate use and staff perception
of the checklist.18 There are, however, a number of reports that
do not include mortality data, and it has been suggested that
this may represent reporting bias.12 Our study makes an im-
portant addition to the literature not only because it includes
by far the largest number of patients, but also because this is
the first study to allow comparison of checklist use and effect-
iveness in different health-care systems. This allows us to
account for differences in national and local health-care pol-
icies. Our effect estimates are consistent with those reported
in a previous systematic review (OR 0.57, CI 0.42–0.76), al-
though the authors also describe significant heterogeneity of
the literature, making interpretation difficult.13 The findings
of a further systematic review also suggested an association
between checklist use and reduced mortality, and the
authors noted that none of the component studies described
any adverse effects on patient outcome.19 The surgical check-
list appears to be a low-cost, effective method that need not
adversely affect operation room efficiency.20 Other studies
suggest a reduction in health-care costs associated with this
intervention, presumably as a result of cost savings through
reduced postoperative morbidity.17 21 The introduction of asur-
gical checklist to the operating theatre environment appears to
improve communication and teamwork within the multidiscip-
linary team, which in turn is associated with improvement in
postoperative outcomes.16 22 However, the assumption that
introduction of a checklist improves communication in the
absence of change in organizational structures has been ques-
tioned. Effective implementation of the surgical checklist
requires strong clinical engagement with adequate staff train-
ing. A failure to do so may result in poor compliance or poor
record keeping regarding checklist use.23 In a recent study
from Canada, the government-mandated implementation of
a surgical checklist was not associated with a decrease in
mortality.24
This prospectively collected data set provides a unique
opportunity to evaluate the effect of the surgical checklist on
hospital mortality. However, our analysis also has some limita-
tions. The EuSOS was a 7 day cohort study of just under 500
hospitals in 28 European countries. The study design was ne-
cessarily pragmatic and not designed specifically to provide
data on checklist use. We did not collect detailed data describ-
ing checklist implementation, such as the type of checklist
used, duration of use, or the approach to implementation. Con-
sequently, this analysis cannot confirm whether the observed
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Fig 1 Proportion of patients exposed to a surgical checklist in different European countries.
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pattern of mortality is the direct result of the checklist itself or
simply a feature of hospital processes which identify patient
care of a higher quality. Data were collected during 1 week in
April, which could mask the possibility of seasonal variation
in outcome. The findings of the primary EuSOS study have
been widely debated and subject to some criticism.25 – 32 In
some countries, the findings appear to differ from those from
alternative data sources. In common with most registry data,
it was not possible to undertake source data verification;
hence, we cannot provide any measure of the quality of data
collected. However, we also note that the findings of several
retrospective analyses have suggested that our data have
face validity, in particular after exclusion of hospitals returning
very small numbers of patients.33 One explanation for the high
mortality in the parent study may be that investigators made
a particular effort to include major or complex surgery, with
the result that low-risk surgical procedures were under-
represented. This would explain the high mortality on the
one hand and the face validity of the data on the other. As in
all epidemiological studies, the approach to hospital inclusion
and patient sampling will influence the results. This could
explain differences in the prevalence of checklist use
between our work and other national studies.34 35 It is also im-
portant to note that the simple prevalence of checklist use may
not represent how carefully and effectively the checklist was
used for individual patients.36 37 Compliance with policies for
checklist use may be lower than indicated by administrative
data,37 38 which may overestimate the true prevalence of
Table 2 Relationship between surgical checklist exposure and hospital mortality as in a three-level hierarchical generalized mixed model.
*Unadjusted odds ratios (ORs) with 95% CIs were constructed for in-hospital mortality including the use of a surgical checklist and the relevant
category in the model. †Mortality without the use of a surgical checklist. Odds ratios were adjusted for baseline risk factors of age, sex, country, ASA
class, urgencyof surgery, grade of surgery, surgical speciality, and the presence of metastatic disease orcirrhosis in a three-level binary generalized
linear mixed model (with patient as first level, hospital as second level, and country as third level). ‡Odds ratios were adjusted for use of a surgical
checklist and the baseline risk factors mentioned above. N/A, not available
Unadjusted OR (95% CI)*
for mortality
Adjusted OR (95% CI) for mortality
excluding surgical checklist in model†
Adjusted OR (95% CI) for mortality
including surgical checklist in model‡
P-value
Checklist use 0.84 (0.75–0.94) N/A 0.71 (0.58–0.85) ,0.001
Age (yrs) 1.02 (1.02–1.03) 1.01 (1.01–1.02) 1.01 (1.01–1.02) ,0.001
ASA class
I Reference Reference Reference –
II 0.99 (0.84–1.17) 0.77 (0.63–0.99) 0.76 (0.63–0.92) 0.01
III 2.14 (1.81–2.52) 1.29 (1.05–1.59) 1.29 (1.05–1.59) 0.02
IV 10.88 (9.00–13.17) 4.47 (3.50–5.72) 4.43 (3.46–5.66) ,0.001
V 56.80 (36.58–88.20) 15.49 (9.35–25.67) 15.40 (9.28–25.55) ,0.001
Grade of surgery
Minor Reference Reference Reference –
Intermediate 0.93 (0.80–1.07) 0.81 (0.69–0.94) 0.81 (0.69–0.95) 0.01
Major 1.98 (1.72–2.29) 1.22 (1.04–1.44) 1.24 (1.05–1.46) 0.01
Urgency of care
Elective Reference Reference Reference –
Urgent 0.93 (0.80–1.07) 1.85 (1.61–2.12) 1.84 (1.60–2.11) ,0.001
Emergency 1.98 (1.72–2.29) 3.08 (2.55–3.71) 3.02 (2.50–3.64) ,0.001
Surgical speciality
Orthopaedics 0.80 (0.63–1.01) 0.79 (0.62–1.02) 0.76 (0.60–0.98) 0.04
Breast 0.77 (0.51–1.15) 1.04 (0.69–1.58) 1.05 (0.69–1.62) 0.79
Gynaecology 0.74 (0.55–0.99) 1.11 (0.81–1.52) 1.05 (0.76–1.44) 0.76
Vascular 1.87 (1.42–2.45) 1.09 (0.82–1.46) 0.94 (0.70–1.23) 0.69
Upper
gastrointestinal
2.35 (1.80–3.06) 1.72 (1.30–2.29) 1.66 (1.23–2.22) ,0.001
Lower
gastrointestinal
1.72 (1.35–2.18) 1.19 (0.92–1.55) 1.15 (0.88–1.50) 0.30
Hepatobiliary 1.24 (0.91–1.68) 1.10 (0.80–1.53) 1.09 (0.79–1.51) 0.60
Plastic or
cutaneous
0.85 (0.61–1.19) 1.05 (0.75–1.48) 0.92 (0.65–1.30) 0.65
Urology 0.81 (0.62–1.07) 0.89 (0.67–1.19) 0.76 (0.56–1.02) 0.07
Kidney 0.46 (0.20–1.06) 0.37 (0.16–0.87) 0.33 (0.14–0.77) 0.01
Head and neck 0.78 (0.59–1.02) 1.17 (0.89–1.55) 1.04 (0.78–1.39) 0.79
Other Reference Reference Reference –
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checklist use in individual patients.35 One factor that may influ-
ence compliance with checklist use is the urgency of surgery. It
is interesting to note, therefore, a similar pattern of findings
associated with checklist use in the EuSOS cohort regardless
of the urgency of the surgical procedure.
Conclusions
The findings of this analysis suggest large variations in preva-
lence of surgical checklist use between European nations for
patients undergoing inpatient non-cardiac surgery. Exposure
to a surgical checklist was associated with reduced hospital
mortality after adjustment for a range of other risk factors in
a multilevel statistical model. This observation may represent
a genuine protective effect of the surgical checklist itself, or
alternatively, this intervention may be an indirect indicator of
quality of patient care.
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